Cargando…
Upregulation of SPINK2 in acute myeloid leukemia
OBJECTIVES: Acute myeloid leukemia (AML) is a highly heterogeneous disease. Although patients can be classified into risk groups based on their genetic changes, the prognosis of disease within these categories varies widely. This situation raises the need to search for new molecular markers related...
Autores principales: | Gezer, Sümbül, Emrence, Zeliha, Elverdi, Tuğrul, Ar, Muhlis Cem, Salman Yaylaz, Burcu, Paçal, Ferda, Ünüvar, Ayşegül, Sarıman, Melda, Eşkazan, Ahmet Emre, Karaman, Serap, Salihoğlu, Ayşe, Karakaş, Zeynep, Abacı, Neslihan, Sırma-Ekmekci, Sema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197194/ https://www.ncbi.nlm.nih.gov/pubmed/37359898 http://dx.doi.org/10.1515/almed-2022-0047 |
Ejemplares similares
-
Elevación de SPINK2 en leucemia mieloide aguda
por: Gezer, Sümbül, et al.
Publicado: (2023) -
LEF1 Induces DHRS2 Gene Expression in Human Acute Leukemia Jurkat T-Cells
por: Sırma Ekmekci, Sema, et al.
Publicado: (2020) -
Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis
por: Sarıman, Melda, et al.
Publicado: (2019) -
Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades
por: Çokgezer, Simay, et al.
Publicado: (2022) -
Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience
por: Öngören, Şeniz, et al.
Publicado: (2017)